Informational only. Not medical advice.INFORMATIONAL PLATFORM ONLY — NOT MEDICAL ADVICE, DIAGNOSIS, OR TREATMENT
Informational only. Not medical advice.INFORMATIONAL PLATFORM ONLY — NOT MEDICAL ADVICE, DIAGNOSIS, OR TREATMENT
orbitrexpeptide.is
Orbitrex Peptides holds a Disclosed Labs trust grade of A (93/100), computed independently from 160 lab Certificates of Analysis (as of July 2026). That's a strong, well-documented track record. Scores come only from lab COAs; vendors can't pay to raise them.
What is Orbitrex Peptides's trust score?
Orbitrex Peptides scores 93/100 (Grade A) on Disclosed Labs, from 160 lab COAs (as of July 2026).
How is Orbitrex Peptides's trust score calculated?
Only from lab-issued Certificates of Analysis — average purity, safety-panel coverage, lab corroboration, and forgery signals. No vendor can pay to change it, and sponsorships never affect it.
Samples
Passed
Failed
Trust score updated: July 14, 2026 · 100% pass rate
Composite score based on 160 COAs attributed to this vendor.
Mean HPLC purity across published COAs
Per-peptide coverage of the safety panels each product form requires — identity, net-content, heavy-metals and residual-solvents for raw powders, plus endotoxin and sterility for injectables. Forms aren't penalized for panels they don't need.
Lab corroboration tier — confirmed via public verify portal (90), presumptive trusted lab (85), lab resolved but unverified (75), or no lab attribution (50)
Texas-based supplier; separate email lines for inquiries (inquiry@) and orders/support (support@).
| Date | Peptide | Test | Result | Purity | Lab | Notes |
|---|---|---|---|---|---|---|
| Jun 30, 2026 | Glutathione | HPLC purity | PASS | 99.74% | Freedom Diagnostics | Lot GL15KC · Report 2606300461 |
| Jun 26, 2026 | BPC-157 / TB-500 | HPLC purity | PASS | 99.95% | ILS Labs | Lot WOLV20726US · Report ACC-2026-5320 |
| Jun 26, 2026 | GHK-Cu | HPLC purity | PASS | 99.95% | ILS Labs |
See how Orbitrex Peptides's $/mg stacks up against every COA-verified vendor — updated daily.
Research profiles — side effects, mechanism, and lab-tested COA data for each peptide in this vendor's catalog.
Every peptide Orbitrex Peptides has a lab-verified Certificate of Analysis for — purity, net peptide content, and contamination panels, per compound.
Add a live, data-driven trust badge to your site or review. It updates automatically when new COAs are indexed — no account required.
Preview
Live badge (JavaScript)
<script async src="https://www.disclosedlabs.com/widget.js" data-vendor="orbitrex-peptides"></script>
Renders the dynamic grade badge. Best visual; the link is injected by script.
Static link (HTML) — best for SEO
<a href="https://www.disclosedlabs.com/vendors/orbitrexpeptide.is" rel="noopener" target="_blank" style="display:inline-flex;align-items:center;gap:8px;padding:8px 12px;border:1px solid #e2e8f0;border-radius:10px;background:#fff;color:#0f172a;text-decoration:none;font:600 13px/1.25 -apple-system,BlinkMacSystemFont,'Segoe UI',Roboto,Helvetica,Arial,sans-serif"> COA Trust Score by Disclosed Labs — independent index of published COAs </a>
A plain, crawlable dofollow link in your page source. This is the version search engines credit.
Both point to Orbitrex Peptides's live profile at https://www.disclosedlabs.com/vendors/orbitrexpeptide.is.
Links back to Orbitrex Peptides's profile — a dofollow link (no sponsored or nofollow tagging). Score updates daily. Dark theme & options →
| 5-Amino-1MQ | vial | 10mg | $59.99 | $6.00 | In stock | 2026-07-21 | View → |
| Adamax | vial | 10mg | $49.99 | $5.00 | In stock | 2026-07-21 | View → |
| AOD-9604 | vial | 5mg | $54.99 | $11.00 | In stock | 2026-07-21 | View → |
| BPC-157 | vial | 10mg | $39.99 | $4.00 | In stock | 2026-07-21 | View → |
| BPC-157 + TB-500 | blend | 20mg | $89.99 | $4.50 | In stock | 2026-07-21 | View → |
| Cagrilintide | vial | 10mg | $99.99 | $10.00 | In stock | 2026-07-21 | View → |
| DSIP | vial | 10mg | $49.99 | $5.00 | In stock | 2026-07-21 | View → |
| Epitalon | vial | 10mg | $39.99 | $4.00 | In stock | 2026-07-21 | View → |
| FOXO4-DRI | vial | 10mg | $189.99 | $19.00 | Sold out | 2026-07-21 | View → |
| GLOW Blend (GHK-Cu + BPC-157 + TB-500) | blend | 70mg | $95.99 | $1.37 | In stock | 2026-07-21 | View → |
| Glutathione | vial | 1500mg | $59.99 | $0.04 | In stock | 2026-07-21 | View → |
| Ipamorelin | vial | 10mg | $59.99 | $6.00 | In stock | 2026-07-21 | View → |
| LL-37 | vial | 5mg | $39.99 | $8.00 | In stock | 2026-07-21 | View → |
| MOTS-c | vial | 10mg | $49.99 | $5.00 | In stock | 2026-07-21 | View → |
| MOTS-c | vial | 40mg | $139.99 | $3.50 | Sold out | 2026-07-21 | View → |
| NAD+COA ✓ | vial | 500mg | $59.99 | $0.12 | In stock | 2026-07-21 | View → |
| OxytocinCOA ✓ | vial | 2mg | $29.99 | $14.99 | In stock | 2026-07-21 | View → |
| Retatrutide | vial | 10mg | $79.99 | $8.00 | In stock | 2026-07-21 | View → |
| Retatrutide | vial | 20mg | $129.99 | $6.50 | In stock | 2026-07-21 | View → |
| Retatrutide | vial | 36mg | $199.99 | $5.56 | In stock | 2026-07-21 | View → |
| Selank | vial | 10mg | $29.99 | $3.00 | In stock | 2026-07-21 | View → |
| Selank | vial | 30mg | $69.99 | $2.33 | Sold out | 2026-07-21 | View → |
| Semax | vial | 10mg | $29.99 | $3.00 | Sold out | 2026-07-21 | View → |
| Semax | vial | 30mg | $69.99 | $2.33 | In stock | 2026-07-21 | View → |
| Sermorelin | vial | 10mg | $79.99 | $8.00 | In stock | 2026-07-21 | View → |
| SLU-PP-332 | vial | 5mg | $49.99 | $10.00 | Sold out | 2026-07-21 | View → |
| SLU-PP-332 | vial | 1mg | $129.99 | $129.99 | In stock | 2026-07-21 | View → |
| SS-31 | vial | 10mg | $79.99 | $8.00 | In stock | 2026-07-21 | View → |
| SS-31 | vial | 50mg | $269.99 | $5.40 | In stock | 2026-07-21 | View → |
| Survodutide | vial | 10mg | $99.99 | $10.00 | In stock | 2026-07-21 | View → |
| TB-500 | vial | 10mg | $59.99 | $6.00 | In stock | 2026-07-21 | View → |
| Tesamorelin | vial | 10mg | $69.99 | $7.00 | In stock | 2026-07-21 | View → |
| Tesamorelin + Ipamorelin | blend | 13mg | $79.99 | $6.15 | Sold out | 2026-07-21 | View → |
| Tesofensine | vial | 0.5mg | $99.99 | $199.98 | In stock | 2026-07-21 | View → |
| Thymosin Alpha-1 | vial | 10mg | $79.99 | $8.00 | In stock | 2026-07-21 | View → |
| Tirzepatide | vial | 10mg | $59.99 | $6.00 | In stock | 2026-07-21 | View → |
| Tirzepatide | vial | 15mg | $69.99 | $4.67 | In stock | 2026-07-21 | View → |
| Tirzepatide | vial | 30mg | $119.99 | $4.00 | In stock | 2026-07-21 | View → |
| Tirzepatide | vial | 60mg | $199.99 | $3.33 | In stock | 2026-07-21 | View → |
| Vasoactive Intestinal Peptide (VIP) | vial | 10mg | $74.99 | $7.50 | In stock | 2026-07-21 | View → |
| Vilon | vial | 20mg | $49.99 | $2.50 | Sold out | 2026-07-21 | View → |
Prices are scraped from orbitrexpeptide.is and may lag the live site. All prices are single-vial / pre-bulk list prices — bulk or bundle deals may be lower. $/mg is derived from the listed strength. “Updated” is when we last verified each listing.
We are continuously testing more products. Scores update with each new result.
Read our scoring methodology →Trust scores are computed from indexed Certificates of Analysis — vendor-published, and lab-confirmed where a lab copy verifies them — using a fixed, versioned methodology (v16). They are not based on independent blind-purchase testing, and no vendor can pay for placement or a higher score. How we score · How we make money
Inverse of CoaFlag count (lot collisions, hash collisions, etc.)
Composite of 160 COAs attributed to this vendor. Last recomputed 2026-07-14.
PMB address (-0.03), Full identity on file (0.03), Lab-confirmed (0.02)
Sources: RDAP/WHOIS for domain data, Twilio Lookup for phone classification, Google Places for address verification. Crawl runs weekly. Signals are independent of vendor-supplied data.
| Lot GHK50726US · Report ACC-2026-5329 |
| Jun 26, 2026 | Tirzepatide | HPLC purity | PASS | 99.68% | ILS Labs | Lot 2G30726 · Report ACC-2026-5335 |
| Jun 26, 2026 | PT-141 | HPLC purity | PASS | 99.94% | ILS Labs | Lot PT10726US · Report ACC-2026-5326 |
| Jun 26, 2026 | Adamax | HPLC purity | PASS | 99.98% | ILS Labs | Lot ADA10726 · Report ACC-2026-5314 |
| Jun 26, 2026 | BPC-157 | HPLC purity | PASS | 99.91% | ILS Labs | Lot BPC10726US · Report ACC-2026-5323 |
| May 4, 2026 | KLOW | HPLC purity | PASS | 99.5% | Vanguard Laboratory | Lot KLOW80426A · Report V260421-4 002 |
| Apr 29, 2026 | Retatrutide | HPLC purity | PASS | 99.8% | Vanguard Laboratory | Lot 3G20526 · Report V260421-4 003 |
| Apr 22, 2026 | Retatrutide | HPLC purity | PASS | 99.85% | Freedom Diagnostics | Lot 3G30526 · Report 2604220146 |
| Apr 20, 2026 | NAD+ (Buffered) | HPLC purity | PASS | 99.97% | Freedom Diagnostics | Lot BNAD500526US · Report 2604200168 |
| Apr 15, 2026 | BPC-157/Thymosin Beta-4 | HPLC purity | PASS | 99.63% | Freedom Diagnostics | Lot WOLV20526US · Report 2604150284 |
| Apr 15, 2026 | GHK-Cu | HPLC purity | PASS | 99.93% | Freedom Diagnostics | Lot GHK50526US · Report 2604150288 |
| Apr 8, 2026 | Tesamorelin | HPLC purity | PASS | 99.14% | Freedom Diagnostics | Lot TS200426 · Report 2604080204 |
| Apr 2, 2026 | GHK-Cu/BPC-157/Thymosin Beta-4 | HPLC purity | PASS | 99.76% | Freedom Diagnostics | Lot GLOW70426 · Report 2604020106 |
| Mar 30, 2026 | Retatrutide | HPLC purity | PASS | 99.63% | Vanguard Laboratory | Lot 3G101125 · Report V260311-13 001 |
| Mar 30, 2026 | DSIP | HPLC purity | PASS | 99.47% | Vanguard Laboratory | Lot DSIP100326 · Report V260311-13 009 |
| Mar 30, 2026 | Tirzepatide | HPLC purity | PASS | 99.75% | Vanguard Laboratory | Lot 2G600426 · Report 2603300106 |
| Mar 25, 2026 | Retatrutide | HPLC purity | PASS | 99.95% | Freedom Diagnostics | Lot 3G200426US · Report 2603250150 |
| Mar 24, 2026 | TB-4/BPC-157 | HPLC purity | PASS | 99.8% | Vanguard Laboratory | Lot WOLV200226 · Report V260311-13 005 |
| Mar 20, 2026 | Retatrutide | HPLC purity | PASS | 99.89% | Freedom Diagnostics | Lot 3G100426US · Report 2603200091 |
| Mar 19, 2026 | Retatrutide | HPLC purity | PASS | 99.96% | Freedom Diagnostics | Lot 3G36426a · Report 2603190080 |
| Mar 17, 2026 | Epitalon | HPLC purity | PASS | 99.71% | Freedom Diagnostics | Lot EPI500426 · Report 2603170164 |
| Mar 17, 2026 | Melanotan-1 | HPLC purity | PASS | 99.84% | Freedom Diagnostics | Lot MT1100426 · Report 2603170156 |
| Mar 17, 2026 | Melanotan-II | HPLC purity | PASS | 99.85% | Freedom Diagnostics | Lot MT2100426 · Report 2603170148 |
| Mar 17, 2026 | Semaglutide | HPLC purity | PASS | 99.83% | Freedom Diagnostics | Lot 1G200426 · Report 2603170144 |
| Mar 17, 2026 | Selank | HPLC purity | PASS | 99.84% | Freedom Diagnostics | Lot SEL100426 · Report 2603170152 |
| Mar 17, 2026 | Semax | HPLC purity | PASS | 99.56% | Freedom Diagnostics | Lot SEM100426 · Report 2603170160 |
| Mar 17, 2026 | Tirzepatide | HPLC purity | PASS | 99.88% | Freedom Diagnostics | Lot 2G100426 · Report 2603170140 |
| Mar 17, 2026 | GHK-Cu/KPV/BPC-157/Thymosin Beta-4 | HPLC purity | PASS | 99.44% | Freedom Diagnostics | Lot KLOW800426 · Report 2603170168 |
| Mar 1, 2026 | SLU-PP-332 | Identity & safety panels | PASS | -- | Vanguard Laboratory | Lot SLU0012026-01 · Report V260218-22002 |
| Feb 25, 2026 | SS-31 | HPLC purity | PASS | 99.81% | Freedom Diagnostics | Lot MTP100326 · Report 2602250058 |
| Feb 24, 2026 | NAD+ | HPLC purity | PASS | 99.93% | Freedom Diagnostics | Lot NAD5000326 · Report 2602240161 |
| Feb 24, 2026 | Ipamorelin/Tesamorelin | HPLC purity | PASS | 99.98% | Freedom Diagnostics | Lot SOM130326 · Report 2602240149 |
| Feb 24, 2026 | Cagrilintide | HPLC purity | PASS | 99.89% | Freedom Diagnostics | Lot CAG100326 · Report 2602240145 |
| Jan 23, 2026 | CJC-1295(no DAC)+Ipamorelin | HPLC purity | PASS | 99.91% | Freedom Diagnostics | Lot CJP10226A · Report 2601230110 |
| Jan 21, 2026 | GHK-Cu/BPC-157/Thymosin Beta-4 | HPLC purity | PASS | 99.68% | Freedom Diagnostics | Lot GLOW70226A · Report 2601210022 |
| Jan 6, 2026 | GLOW (GHK-Cu, BPC-157, TB-500 blend) | HPLC purity | PASS | 99.113% | Chromate | Lot GLOW701225 · Report 30922 |
| Jan 5, 2026 | Semaglutide | HPLC purity | PASS | 99.709% | Chromate | Lot 1G20126 · Report 30915 |
| Jan 5, 2026 | Semaglutide | HPLC purity | PASS | 99.797% | Chromate | Lot 1G10126 · Report 30916 |
| Jan 5, 2026 | LL-37 | HPLC purity | PASS | 99.816% | Chromate | Lot LL5126 · Report 31024 |
| Jan 5, 2026 | Tirzepatide | HPLC purity | PASS | 99.852% | Chromate | Lot 2G150126 · Report 30914 |
| Jan 3, 2026 | DSIP | HPLC purity | PASS | 98.088% | Chromate | Lot DSIP10126 · Report 30871 |
| Dec 31, 2025 | KLOW 80mg | HPLC purity | PASS | 99.85% | Chromate | Lot KLOW801225 · Report 30965 |
| Dec 31, 2025 | KPV | HPLC purity | PASS | 99.654% | Chromate | Lot KPV101225 · Report 30870 |
| Dec 30, 2025 | Teriparatide | HPLC purity | PASS | 98.465% | Chromate | Lot TERA101225 · Report 30855 |
| Dec 30, 2025 | Retatrutide | HPLC purity | PASS | 99.841% | Chromate | Lot 3G20126 · Report 31022 |
| Dec 29, 2025 | 5-Amino-1MQ | HPLC purity | PASS | 99.638% | Chromate | Report 30950 |
| Dec 28, 2025 | LL-37 | HPLC purity | PASS | 99.816% | Chromate | Report 30710 |
| Dec 28, 2025 | MOTS-c | HPLC purity | PASS | 98.972% | Chromate | Report 30850 |
Disclosed Labs